Literature DB >> 23974577

Telogen effluvium.

Chander Grover1, Ananta Khurana.   

Abstract

Telogen effluvium (TE) is one of the most common causes of diffuse nonscarring hair loss. In its acute form, it generates a lot of anxiety in the patient, which can be significantly allayed with a confident diagnosis. In its more chronic form, however, the hair loss may go unnoticed for long periods of time. Here in, the dermatologist's role in differentiating it from the more common patterned hair loss is significant. Differentiating TE from other causes of diffuse nonscarring hair loss can indeed be a daunting task and TE is often used as a waste basket diagnosis. A number of factors have been implicated in the causation of TE, however, clear evidence in their support is lacking. The role of stress as a causative factor as well as the result of hair loss needs to be adequately understood. This review aims at summarizing our current level of knowledge with respect to this very common cause of hair loss. An attempt is made to help the readers reliably differentiate TE from other causes of diffuse nonscarring hair loss. The possible causative factors, pathogenetic mechanisms, clinical presentation, and possible treatment options are discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23974577     DOI: 10.4103/0378-6323.116731

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  25 in total

Review 1.  Bitemporal Scalp Hair Loss: Differential Diagnosis of Nonscarring and Scarring Conditions.

Authors:  Brianna De Souza; Andrea Tovar-Garza; Laura N Uwakwe; Amy McMichael
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

2.  A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women.

Authors:  Shashikant Malkud
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 3.  Platelet-rich plasma-an 'Elixir' for treatment of alopecia: personal experience on 117 patients with review of literature.

Authors:  Suruchi Garg; Shweta Manchanda
Journal:  Stem Cell Investig       Date:  2017-07-18

4.  Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis.

Authors:  Yulia Treister-Goltzman; Shaked Yarza; Roni Peleg
Journal:  Skin Appendage Disord       Date:  2021-11-19

5.  Postpartum Telogen Effluvium Unmasking Traction Alopecia.

Authors:  Aman Samrao; Paradi Mirmirani
Journal:  Skin Appendage Disord       Date:  2022-01-28

Review 6.  Psychological Aspects of Hair Disorders: Consideration for Dermatologists, Cosmetologists, Aesthetic, and Plastic Surgeons.

Authors:  Cameron R Moattari; Mohammad Jafferany
Journal:  Skin Appendage Disord       Date:  2021-11-23

7.  Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.

Authors:  Shahram Seyfi; Robabeh Alijanpour; Zeinab Aryanian; Khadijeh Ezoji; Mahdi Mahmoudi
Journal:  J Med Life       Date:  2022-05

8.  Hair Growth in a Patient with Alopecia Areata on Tocilizumab.

Authors:  Chloe J Walker; Kelly E Flanagan; James T Pathoulas; Isabel Pupo Wiss; Maryanne M Senna
Journal:  Skin Appendage Disord       Date:  2021-06-09

9.  Possible Relationship between Chronic Telogen Effluvium and Changes in Lead, Cadmium, Zinc, and Iron Total Blood Levels in Females: A Case-Control Study.

Authors:  Abeer M Abdel Aziz; Sameera Sh Hamed; Mohammad A Gaballah
Journal:  Int J Trichology       Date:  2015 Jul-Sep

10.  Hair loss in children: common and uncommon causes; clinical and epidemiological study in jordan.

Authors:  Khitam Al-Refu
Journal:  Int J Trichology       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.